ÂÜÀòÂÒÂ×

Ramon Alemany is Doctor in Biology/Genetics by the University of Barcelona, Spain. In 1993 he began working on adenoviruses for cancer gene therapy as a postdoct at the MD, Anderson Cancer Center, Houston, TX. His research on adenoviral vectors and oncolytic adenoviruses applied to cancer therapy continued in Baxter Healthcare, Round Lake, IL, and later at the University of Alabama in Birmingham, AL. In 2001 he returned to Barcelona to lead a research a group on cancer virotherapy at the Catalan Institute of Oncology. He has published more than 100 original articles and 14 patents on the therapeutic use of adenovirus against cancer. In 2009 he co-founded VCN Biosciences.